ALLERGAN INC·4

Jul 27, 4:17 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Jul 27, 2005

Insider Transaction Report

Form 4
Period: 2005-07-25
EVANS HANDEL
Director
Transactions
  • Award

    Phantom Stock Units

    2005-07-25$84.80/sh+11.79$1,00027,947.04 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2005-07-26$85.42/sh+23.41$2,00027,982.24 total
    Common Stock (0 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.

Documents

1 file
  • 4
    eva395.xmlPrimary